Skip to content
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Clinical Topics
View All
Addiction
Anxiety
Bipolar Disorder
Depression
Difficult to Treat Depression
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Auvelity: Information from Industry
Banner Alzheimer’s Institute
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
Rounds in the General Hospital
Joseph C. C. Chen, MSc
JCP
Original Research
Intravenous Scopolamine Versus Active Placebo in MDD
August 15, 2022
Scopolamine, an agent commonly used for motion sickness, has shown promise in treating depression. This study measured its efficacy in major depressive disorder versus an active placebo comparator.
Joseph C. C. Chen
,
Rachael L. Sumner
,
Venkat Krishnamurthy Naga
, et al